Correction

As a follow-up to the article published in the May 2018 issue, "Short-term ibrutinib therapy suppresses skin test responses and eliminates IgE-mediated basophil activation in adults with peanut or tree nut allergy" (J Allergy Clin Immunol 2018;141:1914-6), the authors have provided an additional figure presenting an alternative format of data in the paper's original Fig 1. The authors note, "In presenting our work during talks, we have been asked more specifically about individuals' skin test responses before and during ibrutinib therapy, which we now realize is not easily discernible in the published version of Figure 1 because we regrettably did not include connecting lines between data points for each subject. (Source: Journal of Allergy and Clinical Immunology)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2NoN3wm